Cardiovascular and Interventional Radiological Society of Europe

September 10-14 | Barcelona, Spain

Science for people

September 10-14 | Barcelona, Spain

Science for people

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

Science for people
Slider
ProgrammeCIRSE meetsCIRSE meets EANM

CIRSE meets EANM

Intra-arterial delivery of radionuclide – new frontiers

Monday, September 12, 2022, 11:30-12:30 CEST

Moderators: M. Lam (Utrecht/NL), L. Defreyne (Ghent/BE)

Introduction
M. Lam (Utrecht/NL)

The evolution of dosimetry in radioembolisation for HCC: a nuclear medicine perspective
E. Garin (Rennes/FR)

Radiation segmentectomy for early HCC in curative intent: the results of the RASER study
E. Kim (New York, NY/US)

Intra-arterial liver directed PRRT in metastatic neuroendocrine tumours: dead or alive?
M. Lam (Utrecht/NL)

Targeting primary brain tumours via intra-arterial PRRT
M. Lam (Utrecht/NL)

What´s next in intra-arterial delivery of radionuclide therapy?
M. Weber (Essen/DE)

Closing remarks
M. Lam (Utrecht/NL)

About EANM

The European Association of Nuclear Medicine (EANM) is the largest organisation dedicated to nuclear medicine in Europe.

The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the concept of personalised healthcare. The EANM acts as the umbrella organisation for individuals as well as national societies.

The goal of the EANM is to be a platform for the dissemination and discussion of the latest results in the field of nuclear medicine including multimodality imaging and related subjects. It fosters and coordinates the mutual exchange of knowledge relating to the diagnosis, treatment and prevention of diseases through the use of unsealed radioactive substances and the properties of stable nuclides in medicine.

The EANM is a professional non-profit medical association incorporated in Vienna, Austria. The EANM membership comprises physicians, scientists, technologists as well as other persons working in nuclear medicine or related fields in Europe and beyond.